New Molecules to Block Cancer Growth
Author Information
Author(s): Claringbold Bini, Vance Steven, Paul Alexandra R., Williamson James, Garrett Michelle D., Serpell Christopher J.
Primary Institution: University of Kent
Hypothesis
Can synthetic phosphoestamers selectively inhibit the KRASG12D/RAF1 interaction?
Conclusion
The study identified six novel phosphoestamers that effectively inhibit the KRASG12D/RAF1 interaction, with some showing high selectivity for the mutant form over the wild type.
Supporting Evidence
- The phosphoestamers showed IC50 values as low as 25 nM against KRASG12D.
- Three phosphoestamers were selective for the mutant KRASG12D over the wild type.
- The study provides proof-of-concept for using phosphoestamers to target protein-protein interactions.
Takeaway
Scientists created new molecules that can stop cancer cells from growing by blocking a specific interaction that helps them grow.
Methodology
The study used a library of synthetic phosphoestamers and selected those that inhibit the KRASG12D/RAF1 interaction through fluorescence-activated bead sorting.
Limitations
The pharmacokinetic challenges associated with large, polyanionic compounds may limit their effectiveness as drugs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website